Results 251 to 260 of about 81,856 (291)

Effectiveness of Intranasal Esketamine on Suicidal Ideation and Depressive Symptoms in Patients with Treatment-Resistant Depression: A Longitudinal Study. [PDF]

J Clin Med
Leonardi M, Frediani A, Angeletti MC, Biseo M, Versaci G, Castiglioni M, Olivola M, Vismara M, Varinelli A, Bosi M, Benatti B, Brondino N, Dell'osso BM.   +12 more
europepmc   +1 more source

Ketamine Combined With Psychotherapy as a Treatment for Resistant Depression in a Public European Hospital. [PDF]

Brain Behav
Silva FAD, Avelar R, Peixoto B, Bacelar-Nicolau L, Santos F, Ribeiro JC, Heitor MJ.   +6 more
europepmc   +1 more source

Risk factors for treatment resistance among women with postpartum depression in a nationwide study. [PDF]

Nat Ment Health
Chen Y, Bränn E, Bendix M, Joyce EE, Fransson E, Lu Y, Skalkidou A, Lu D.   +7 more
europepmc   +1 more source

Efficacy of Oral Ketamine in Patients with Depression and Suicidality: A Retrospective Study. [PDF]

Indian J Psychol Med
Wani ZA, Raj R, Dar SA, Haq I.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Brexpiprazole for treatment-resistant major depressive disorder

Expert Opinion on Pharmacotherapy, 2019
Introduction:Treatment-resistant depression (TRD), seldom interchangeably referred to as 'depression inadequately responding to the standard antidepressant drug,' carries a significant burden. The atypical antipsychotics represent a popular augmentation strategy for antidepressant-resistant depression, although their efficacy/safety profiles vary ...
Fornaro M., Fusco A., Anastasia A., Cattaneo C. I., De Berardis D.   +4 more
openaire   +3 more sources

Axis III disorders in treatment-resistant major depressive disorder

Psychiatry Research, 2003
A number of naturalistic studies have found that medical co-morbidity conveys a worse long-term prognosis in the treatment of major depressive disorder (MDD). The purpose of this study was to test whether the presence of co-morbid medical conditions can predict clinical response in patients with treatment-resistant MDD (TRD) treated with open-label ...
George I, Papakostas, Timothy, Petersen, Dan V, Iosifescu, Pamela A, Roffi, Jonathan E, Alpert, Jerrold F, Rosenbaum, Maurizio, Fava, Andrew A, Nierenberg   +7 more
openaire   +2 more sources

Intravenous Ketamine for Treatment-Resistant Major Depressive Disorder

Annals of Pharmacotherapy, 2012
OBJECTIVE: To evaluate the literature regarding the efficacy and safety of intravenous ketamine for treatment-resistant major depressive disorder (MDD). DATA SOURCES: A MEDLINE search (1966-September 2011) was performed using the terms treatment-resistant depression and ketamine.
Jordan R, Covvey, Alexis Noble, Crawford, Denise K, Lowe   +2 more
openaire   +2 more sources

The bipolar diathesis of treatment-resistant major depressive disorder

International Journal of Psychiatry in Clinical Practice, 2008
Objective. In this study, we determined the prevalence of bipolarity in patients with treatment-resistant depression (TRD) by investigating demographic and clinical characteristics, diagnostic subtypes and illness outcome of patients with resistant depression. Methods.
Young Sup, Woo, Jeong-Ho, Chae, Tae-Youn, Jun, Kwang-Soo, Kim, Won-Myong, Bahk   +4 more
openaire   +2 more sources